Skip to content
Bomb Report – Lifestyle
Author:
IRLAB Therapeutics
IRLAB Secures Milestone Payment for First Patient Dosed in Phase Ib Study with IRL757 in Parkinson’s Disease
March 5, 2026
IRLAB Publishes Full-Year Report for The Period January – December 2025
March 5, 2026
←
Previous Page
1
2